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Abstract: A major challenge in cardiovascular tissue en-
gineering is the fabrication of scaffolds, which provide
appropriate morphological and mechanical properties
while avoiding undesirable immune reactions. In this
study electrospinning was used to fabricate scaffolds out
of blood proteins for cardiovascular tissue engineering.
Lyophilised porcine plasma was dissolved in deionised
water at a final concentration of 7.5% m/v and blended
with 3.7% m/v PEO. Electrospinning resulted in homoge-
neous fibre morphologies with a mean fibre diameter of
151 nm, which could be adapted to create macroscopic
shapes (mats, tubes). Cross-linking with glutaraldehyde
vapour improved the long-term stability of protein based
scaffolds in comparison to untreated scaffolds, resulting
in a mass loss of 41% and 96% after 28 days of incubation
in aqueous solution, respectively.
Keywords: biopolymer solution; biostability analysis;
blood protein based scaffold; cross-linking; electrospin-
ning; glutaraldehyde vapour; long-term stability; tissue
engineering.
1 Introduction
Worldwide, 17.5 million people died of cardiovascular dis-
eases in 2012. With a percentage of 46.2%, these diseases
represent the largest cause of total deaths [1]. Current ther-
apeutic approaches include alloplastic vascular prosthe-
ses (Dacron®, Teflon®) to replace or bypass the diseased
vessel. However, the use of such prostheses represents
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several limitations like activation of foreign body reactions
or chronic inflammation [2]. Therefore, the development
of a suitable material for the replacement of diseased
vascular tissue is desirable.
The aim of tissue engineering is a functional tissue
replacement by culturing cells on suitable scaffolds.
Therefore, it is important to develop biocompatible scaf-
folds for cardiovascular applications that have no undesir-
able effects on the surrounding tissue [3]. Electrospinning
is a promisingmethod for the fabrication of biocompatible
fine-fibres andporous scaffolds [4–6]. To reduce undesired
immune reactions for patients, the use of biopolymer so-
lutions from blood proteins is desirable because proteins
contain specific structural and functional information and
are biodegradable. The biodegradable scaffolds will be
gradually replaced by infiltrating and proliferating cells,
leading to an effective tissue remodelling. A disadvan-
tage of choosing electrospun protein based scaffolds is
their high hydrolytic degradation rate in a physiological
environment [7].
The aim of this study is to develop an electrospin-
ning setup for the fabrication of blood protein based
patient-specific scaffolds for cardiovascular applications.
In addition, cross-linking with glutaraldehyde vapour will
be performed and its influence on long-term biostability
has to be analysed.
2 Material and methods
2.1 Biopolymer solution for electrospinning
Anti-coagulated porcine blood from the slaughterhouse
was centrifuged with ≈ 2000 rcf (relative centrifugal
force, Heraeus Megafuge 1 S-R, Thermo Fisher Scien-
tific) for 10 min to separate blood components. Cell count
(Advia120, Siemens) and protein concentration (Pierce
BCA Protein Assay Kit, Thermo Fisher Scientific) were
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Table 1: Composition and concentration of biopolymer solutions
used for the fabrication of electrospun protein based scaffolds.
Solution Concentration (mg/ml) Concentration of
heparin (µl/ml)PPlas PEO Span85
I – 37 – –
II 100 37 – 0.4
III 75 37 – 0.3
IV 75 37 50 0.3
V 75 37 100 0.3
Polymers were dissolved in deionised water on a shaker for at least
72 h.
measured to characterise resulting blood plasma. Blood
protein powder was created by lyophilisation. Biopoly-
mer solutions were blended with non-toxic synthetic
and water-soluble polyethylene oxide (PEO) to improve
spinnability [7]. The lyophilised porcine plasma (PPlas)
and PEO (400 kDa, Sigma-Aldrich) were dissolved in
deionised water on a shaker for at least 72 h. Heparin
(5000 IE/ml, Biochrom) was added to avoid coagula-
tion. Different concentrations and blends were tested (see
Table 1). Sorbitan trioleate (Span85, Sigma-Aldrich) was
added for adjusting surface tension. Solution parameters
like density, viscosity, surface tension and conductivity
were measured to investigate their influence on the elec-
trospinning process.
2.2 Scaffold fabrication and assessment
of nanofibres morphology
Electrospinning was performed with a flow rate of
0.75 ml/h and an applied voltage of 20 kV. Two blunt
cannulas (Ø = 0.4 mm)were arranged at 45° to the collec-
tor to improveprocess stability andefficiency. Thedistance
between cannulas and the collector was set to 180 mm. A
rotating-drum collector (b = 120 mm, Ø = 150 mm) was
used at a rotation velocity of 250 rpm toproducefibremats.
Tubular scaffolds were fabricated with a mandrel collec-
tor (Ø = 6 mm). Fibre mats and tubular scaffolds were
spun for 4 h. Morphological properties of protein based
scaffolds were analysed via scanning electron microscopy
(SEM, Hitachi S-3400N). Wall thickness and fibre diameter
were measured using digital image processing software
“AxioVision” (Carl Zeiss).
2.3 Biostability analysis and cross-linking
method
To assess the in vitrodegradation behaviour of electrospun
protein based scaffolds, real time biostability analysis
according to DIN EN ISO 10993-13:2010 [8] was performed
with a test period of 1 to 28 days in a statically simulated
body environment. Scaffolds were cross-linked with glu-
taraldehyde vapour to increase their long-term stability.
In addition, untreated protein based scaffolds as well as
treated and untreated PEO scaffolds served as control (see
Table 2). PEO scaffolds were electrospun with comparable
process parameters used for the protein based scaffolds.
All scaffoldswere placed in gas-tight boxes,which allowed
to separate them from liquid glutaraldehyde agent (25%,
Carl Roth) but leading to an incubation in glutaraldehyde
vapour. They stayed in an incubator (Memmert) for 4 h
with a chamber temperature of 37°C. Finally, the scaffolds
were degassed for at least 12 h, cut into samples of≈ 50mg,
and sterilized with ultraviolet radiation for 20 min. Af-
terwards each sample was incubated in 1.5 ml phosphate
buffered saline containing 1%v/vpenicillin/streptomycin-
solution (10,000 IE/ml, 10,000 µg/ml, Biochrom).
3 Results and discussion
3.1 Biopolymer solution characteristics
According to Stokes formula, dynamic viscosity increases
with lower fluid density. The lowest value of 2.69 MPa·s
was detected for a concentration of 10% m/v PPlas and
3.7% m/v PEO (density: 1.0303 g/cm3) and increased with
decreasing mass fraction of PPlas (7.5% m/v, density:
1.0219 g/cm3) to 3.37 MPa·s. The viscosity for the solution
with Span85 5% m/v (density: 1.0191 g/cm3) is 3.56 MPa·s
and for 10% m/v (density: 1.0159 g/cm3) 4.04 MPa·s.
Pure PEO (3.7% m/v) has the highest value viscosity of
4.17 MPa·s (density: 1.0027 g/cm3).
The surface tension of biopolymer solutions without
Span85 is dominated by the surface tension of deionised
water with 60.54 mN/m (10% m/v PPlas), 60.22 mN/m
(7.5% m/v PPlas) and 60.00 mN/m (pure PEO). The ad-
dition of Span85 in a concentration of 5% m/v lead to a
decrease in surface tensiondown to 36.11 mN/m (7.5% m/v
Table 2: Study design for biostability analysis.
Day 1 Day 3 Day 7 Day 14 Day 28
i n = 3 n = 4 n = 4 n = 5 n = 5
ii n = 5 n = 4 – – –
iii n = 3 n = 3 – – –
iv n = 3 – – – –
i: with glutaraldehyde vapour treated protein based samples;
ii: untreated protein based samples; iii: with glutaraldehyde vapour
treated pure PEO samples; iv: untreated pure PEO samples.
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Figure 1: SEM-image of a resulting electrospun fibre mat with
the concentration of 7.5% m/v PPlas and 3.7% m/v PEO.
Visible are smooth and beadless nanofibres.
PPlas) and with a concentration of 10% m/v Span85 to
33.23 mN/m (7.5% m/v PPlas). In low concentrations the
surfactant reduces the interfacial tension between two
phases by accumulate the surfactant molecules at the
molecular interface [9]. The addition was done to adjust
surface tension of the solution, without affecting its con-
ductivity, due to the non-ionic property of Span85 [9].
However, high values of conductivity were measured for
all biopolymer solutions, except pure PEO (2.15 µS/cm),
with the highest value of 226.83 µS/cm for the 10% m/v
PPlas and 3.7% m/v PEO solution. For the 7.5% m/v PPlas
and 3.7% m/v PEO solution a value of 160.90 µS/cm was
measured. With solution additive Span85, the conductivi-
ties were around this value (162.17 µS/cm for 5% m/v and
152.15 µS/cm for 10% m/v) and show the neutrality of this
solution additive.
3.2 Electrospinning of blood protein based
solution
Homogeneous electrospun fibre mats could be fabricated
with a solution of 7.5% m/vPPlas and 3.7% m/v PEO. Fibre
mats showed a microstructure made of beadless nanofi-
bres with a mean fibre diameter of 151 nm (see Figure 1).
3.3 Degradation of electrospun scaffolds
After chemical treatment with glutaraldehyde vapour, the
samples showed colour differences. Chemically treated
protein scaffolds (7.5% m/vPPlas and 3.7% m/vPEO)were
brownish while untreated samples remained white. This
is an indication for the reaction of glutaraldehyde vapour
with the amino groups of the protein molecules. Colour
differences within one sample can be explained by local
inhomogeneities with areas of increased PEO or protein
concentration.
Figure 2: SEM-image of cross-linked protein based samples.
A fibrous structure exist after biostability analysis over all time
intervals (A: day 1; B: day 7; C: day 28). Salt crystal growth is
observed after day 7.
Samples were removed from the fluid after specified
time intervals and weight loss of the samples and pro-
tein concentrations of the fluids were measured. Treated
and untreated samples of pure PEO and untreated pro-
tein scaffolds degraded within a short period of time.
After the first study interval (day 1 and 3) they showed
a mean weight loss of 96%. The mean protein concen-
tration of the degradation solutions was nearly 10 mg/ml
for all untreated protein based samples. The results
show that PEO is not affected by cross-linking with glu-
taraldehyde vapour anduntreated plasmaproteins remain
water-soluble after electrospinning. In contrast, cross-
linking of protein based samples prevented the com-
plete degradation. This was confirmed by the SEM-images
(see Figure 2), showing a fibrous structure for all time
points.
The mean weight loss of 41% after 28 days and the
mean protein concentrations of 3.3 mg/ml proof a good
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Figure 3: Plot of the measured mean values of weight loss
(dark gray) and protein concentration (light gray) of cross-linked
protein based samples with details of the minimum and maximum
values (* measurement error, n = 3–5).
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Figure 4: Electrospun tubular protein based scaffold treated with
glutaraldehyde vapour (diameter: 6 mm, length: 20 mm).©: Daniel
Kühnhold, 2016.
biostability of protein based scaffolds (see Figure 3). Dur-
ing the first days of incubation non-cross-linked proteins
and water-soluble PEO would go in solution. After 3 or
rather 7 days the mean weight loss corresponds approxi-
mately to the incorporated mass of PEO (33% m/v). In ad-
dition thefinalweight loss of 41%wasonly8%higher com-
pared to the incorporated weight of PEO with 33% m/v.
This stands for low protein release, proving an efficient
cross-linking method.
3.4 Tubular electrospun scaffold
A tubular scaffold was successfully spun from a 7.5% m/v
PPlas and 3.7% m/v PEO biopolymer solution and
cross-linked with glutaraldehyde vapour (see Figure 4).
The mean wall thickness of the scaffold was 56.37 µm and
the length about 20 mm.
4 Conclusion and outlook
The aim of this study was to develop a setup for the
electrospinning of blood protein based solutions to cre-
ate patient-specific scaffolds. Furthermore, a cross-linking
method to increase the long-term stability of such water-
soluble protein based scaffolds was established. Based on
a biopolymer solution with 7.5% m/v lyophilised porcine
plasma and 3.7% m/v PEO electrospinning led to ho-
mogeneous scaffold morphology. Scaffolds showed a fi-
brous network with beadless fibres in the nanometer
scale (Ø = 151 nm). A biostability analysis showed that
the cross-linking of protein based samples prevented their
complete degradation over the study period of 28 days.
Furthermore a tubular protein based scaffold could be
electrospun.
The experimental results of this study are promis-
ing for cardiovascular tissue engineering and further
investigations into fabricating patient-specific tubular
scaffolds via electrospinning of blood protein solutions
blended with PEO. For an optimization of hemocompati-
bility further tests should be considered for cross-linking
with native products, like thrombin, without the use of po-
tentially toxic glutaraldehyde vapour. To raise cell prolif-
eration it is possible to enhance electrospinning of protein
based solution with the use of platelet rich plasma.
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